TSX open
Loading markets…

Advertisement

Stocks/TSX/FRX

Fennec Pharmaceuticals Inc (FRX : TSX)

Common Stock

$13.85

CAD

+0.00 (%)

Last updated: 2026-07-31

Get FRX alerts:

FRX

Fennec Pharmaceuticals Inc

Source:WealthAwesomeWealthAwesome
$1.16 (9.14%)
30 day period
$12.69$14.05$15.42Jun 18Jul 10Jul 31

Performance

1 Day

+0.00%

1 Week

-0.72%

1 Month

-9.60%

YTD

+33.05%

Key Statistics

Market Cap

$484.58M

52W High

$15.48

52W Low

$7.59

P/E Ratio

-

50 Day MA

$13.93

200 Day MA

$11.41

Beta

1.07

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Below 50 SMA

Price vs 200-Day SMA

Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
7/31/2026$13.85$13.85$13.85$13.85$13.85200
7/30/2026$13.85$13.85$13.85$13.85$13.85125
7/29/2026$13.95$13.95$13.95$13.95$13.950
7/28/2026$13.85$14.40$13.85$13.95$13.951,949
7/27/2026$14.65$14.65$14.65$14.65$14.65412
7/24/2026$14.22$14.22$14.22$14.22$14.220
7/23/2026$14.22$14.22$14.22$14.22$14.220
7/22/2026$14.22$14.22$14.22$14.22$14.220
7/21/2026$14.22$14.22$14.22$14.22$14.220
7/20/2026$14.22$14.22$14.22$14.22$14.220

Analyst Price Targets

Based on analyst covering FRX

📈

Wall Street analysts forecast FRX stock price to rise 575.6% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$93.57

+575.6% Upside

Current Price

C$13.85

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on FRX's historical volatility

HistoricalForecast68%95%
C$7.86C$12.37C$16.89C$21.40C$25.92C$30.43TodayMar 17May 26Jul 31Sep 12Oct 26Dec 8

30-Day Vol

48.5%

Annualized

90-Day Vol

82.5%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$16.56

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$14.70C$12.44C$17.37
60 trading daysC$15.60C$12.32C$19.76
90 trading daysC$16.56C$12.39C$22.12

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Fennec Pharmaceuticals Inc

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Financials

Revenue (TTM)
$51.00M
EBITDA
$-5.49M
Profit Margin
-16.42%
ROE (TTM)
-52.68%
EPS (Diluted)
-0.41
Book Value
1.55

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About FRX

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
TSATTelesat Corp$76.84+47.57%
INC-UNIncome Financial Trust$10.30+24.85%
TINYTiny Ltd.$7.50+24.38%
TLOTalon Metals Corp$6.04+20.08%
IEIvanhoe Energy Inc$14.98+19.84%
SXGCSouthern Cross Gold Consolidated Ltd.$10.69+18.78%
AYAAya Gold & Silver Inc$32.18+16.85%
TKOTaseko Mines Ltd$11.01+16.38%

FRX.TO news timeline

15 articles covering FRX.TO, most recent first

Latest

Why Fennec Pharmaceuticals Inc stock is skyrocketing today

Stocks

Advertisement